HSPE1P23

Across TCGA pan-cancer cohorts, HSPE1P23 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated HSPE1P23 data layer.

The strongest signal is observed in thymoma (THYM), where higher HSPE1P23 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated HSPE1P23 expression acts as an unfavorable survival marker.

THYM, UCEC, and ACC are the cancer types where HSPE1P23 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Tertile	III,IV	0.103	0.944	<.001	126	view →
UCEC	OS	Tertile	III,IV	0.055	0.592	<.001	66	view →
ACC	OS	Tertile	All	0.268	0.802	.010	36	view →
KIRC	DFS	Tertile	III,IV	0.255	0.758	<.001	24	view →
THCA	OS	Tertile	All	0.712	0.966	.008	21	view →
STAD	DFS	Quartile	II,III,IV	0.355	0.558	.014	12	view →
SARC	DFS	Tertile	All	0.255	0.520	.020	12	view →
SKCM	OS	Tertile	III,IV	0.216	0.721	.001	9	view →
LIHC	DFS	Tertile	All	0.014	0.527	<.001	9	view →
PRAD	OS	Tertile	All	0.957	0.995	.030	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

HSPE1P23–THYM (OS)

Open the THYM breakdown →